New7

New7

New7 related products

Structure Cat No. Product Name CAS No. Product Description
V4505 JNJ-54175446 1627902-21-9 JNJ-54175446 (JNJ54175446) is a novel, potent and selective brain penetrantP2X7 receptorantagonist being developed for treating major depressive disorder.
V4514 JNJ-61432059 2035814-50-5 JNJ-61432059 is a novel, potent, oral bioactive and selective negative modulator ofAMPAR (α-amino-3-hydroxy-5-methylisoxazole-4-propionate receptors)associated with trans-membrane AMPAR regulatory protein (TARP) γ-8, with apIC50of 9.7 for GluA1/γ-8.
V4512 JNJ4796 2241664-16-2 JNJ4796 is a novel, potent and oral bioactive fusion inhibitor of influenza virus, which neutralizes influenza A group 1 viruses by inhibiting hemagglutinin (HA)-mediated fusion.
V4789 K-Ras G12C-IN-1 1629265-17-3 K-Ras G12C-IN-1 is a novel, potent and irreversible/covalent inhibitor of K-Ras protein with G12C mutation.
V4788 K-Ras G12C-IN-2 1629267-75-9 K-Ras G12C-IN-2 is a novel, potent and irreversible/covalent inhibitor of K-Rasprotein with G12C mutation.
V4790 K-Ras G12C-IN-3 1629268-19-4 K-Ras G12C-IN-3 is a novel, potent and irreversible/covalent inhibitor of K-Rasprotein with G12C mutation.
V4838 KKI 5 97145-43-2 KKI 5 is, a synthetic peptide, is a novel and potent serine protease inhibitor that inhibits kallikrein and plasmin.
V4784 KRas G12C inhibitor 1 2158297-28-8 KRAS G12C inhibitor 1 is a novel and potent inhibitor of KRAS.
V4785 KRas G12C inhibitor 2 2206735-61-5 KRAS G12C inhibitor 2 is a novel and potent inhibitor of KRAS.
V4786 KRas G12C inhibitor 3 2206735-75-1 KRAS G12C inhibitor 3 is a novel and potent inhibitor of KRAS.
V4783 KRas G12C inhibitor 4 2206736-07-2 KRas G12C inhibitor 4 is a novel and potent inhibitor of KRAS.
V4787 KRas G12C inhibitor 5 2158297-63-1 KRAS G12C inhibitor 5 is a novel and potent inhibitor of KRAS.
V4801 KX-01-191 2211903-84-1 KX-01-191 (compound 5c′) is a tin reagent precursor.
V5159 L 601920-0 (Methyl-3β-hydroxycholenate) 20231-57-6 Methyl-3β-hydroxycholenate is a ROR gamma modulator.
V4973 Lanosterol 79-63-0 Lanosterol, a naturally-occurring triterpenoid derivative, is a key imtermediate in the biosynthesis of Cholesterol.
V5128 Lck inhibitor II 918870-43-6 Lck inhibitor II is a novel, potent, cell-permeable, ATP competitive amd tri-substituted pyrimidine that acts as a highly potent Lck (lymphocyte specific kinase) inhibitor with the potential for cancer treatment.
V4664 LEQ-506 1057677-92-5 LEQ-506 (also known as NVP-LEQ506) is a novel, orally bioavailable and second-generation small-molecule inhibitor ofsmoothened(Smo) withIC50s of 2 and 4 nM in human and mouse, respectively.
V4868 Lometrexol disodium 120408-07-3 Lometrexol is a novel and potent antimetabolite that belongs to the folate class with antineoplastic activity.
V4844 LY 178002 107889-32-7 LY 178002 is a novel and potent inhibitor of5-lipoxygenase,phospholipase A2withIC50of 0.6 μM for 5-1ipoxygenase, it inhibits cellular production of LTB4 by human polymorphonuclear leukocytes, and shows relatively weak inhibition oncyclooxygenase.
V4842 LY 222306 154446-98-7 LY 222306 is an inhibitor (blocker/antagonist) of glycinamide ribonucleotide formyltransferase ((GARFT)) with Ki of 0.77 nM.
Contact Us Back to top